Visudyne (verteporfin) is a small molecule pharmaceutical. Verteporfin was first approved as Visudyne on 2000-04-12. It is used to treat choroidal neovascularization in the USA. It has been approved in Europe to treat degenerative myopia and macular degeneration.
|Indication||choroidal neovascularization, degenerative myopia, macular degeneration|
|Drug Class||Benzoporphyrin derivatives|